{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-001324","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.375748+00:00","generated_at":"2026-06-27T04:50:20.176152+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Joint Corp. Q4 revenue $22.4M (+32% YoY); net income $224K; guides FY22 rev $102-106M","bullets":["Full-year 2021 revenue $81.2M (+38% YoY); system-wide sales $361.1M (+39%).","Net income $7.2M for 2021 vs. $13.2M in 2020; Adjusted EBITDA $13.3M vs. $9.1M.","Opened 130 clinics in 2021 (110 franchised, 20 greenfield); total 706 clinics at year-end.","Q4 net income $224K ($0.01 diluted EPS) vs. $10.6M ($0.72) in Q4 2020, which included $8.9M tax benefit.","Guides 2022 revenue $102-106M, Adjusted EBITDA $15-17M, and 160-180 total new clinics."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-001324","json":"https://secwatch.observer/filing/0001171843-22-001324.json","markdown":"https://secwatch.observer/filing/0001171843-22-001324.md","text":"https://secwatch.observer/filing/0001171843-22-001324.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322001324/0001171843-22-001324-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322001324/f8k_022422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:50:20.176152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}